Prostate Cancer Salvage Combo Benefits Confirmed
Final results of a phase 3 trial confirm the progression-free survival (PFS) benefit of adding short-term androgen suppression to radiotherapy... Read More
Active Surveillance May Be Safe for Selected Men With Gleason 3+4 Prostate Cancer
New findings support the safety of including selected men with Gleason 3+4 prostate cancer in active surveillance (AS) programs, Australian researchers reported... Read More
Predictors of Adverse Pathology After Prostate Cancer Surgery ID’d
PSA level greater than 4.5 ng/mL and the presence of more than 2 positive biopsy cores are the optimal values... Read More
Lower Disease-Specific Mortality Seen With Early Detection of Prostate Cancer
Early detection of prostate cancer in the United States has resulted in a decrease in the number of men presenting... Read More